Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Helicobacter pylori (H. pylori) is one of the most prevalent bacterial infections within the world and has been clearly associated with peptic ulcer disease, gastric adenocarcinoma, gastric Mucosa-associated Lymphoid Tissue (MALT) lymphomas, idiopathic thrombocytopenia purpura, sideropenic anemia and vitamin B12 deficiency. Multiple worldwide studies have been conducted to identify the optimal therapeutic regimen for H pylori. This article aims to review the evidence behind triple therapy, quadruple therapy, sequential therapy and other therapeutic regimens in the eradication of this problematic disease.
https://www.omicsonline.org/open-access/management-of-helicobacter-pylori-infection-2329-891X.1000129.php?aid=22484
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi